MS News Today podcast: Interview with Gretchen Hawley
Jenn chats with Gretchen Hawley, a Doctor of Physical Therapy, and a Multiple Sclerosis Certified Specialist. Dr. Hawley utilizes the concept of neuroplasticity to help her clients reduce fatigue, get stronger, improve their balance, and walk better. Listen in as Dr. Gretchen shares practical and helpful tips and suggestions on how everyone with MS can benefit from specifically catered physical therapy.
Now that a third COVID-19 vaccine shot has been approved in the U.S. for immunocompromised people, and vaccine boosters are expected to be available to the general public sometime after Sept. 20, Walgreens and CVS have lost no time in offering the additional shot to those who qualify. Like their previous policies for vaccine shots and […]
Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity — or muscle stiffness and spasms — in adults with multiple sclerosis (MS), remains unavailable to many patients there, according to a report by the MS Society UK. Sativex is the only licensed form of medical cannabis for MS in the U.K., […]
PoNS, a non-invasive devise to accompany physical therapy in multiple sclerosis (MS) patients with difficulty walking, will be available on the U.S. market early next year, its developer, Helius Medical Technologies, announced in a quarterly financial update. Short for Portable Neuromodulation Stimulator, the PoNS system was cleared by the U.S. Food and Drug Administration (FDA) in […]
Now that a third COVID-19 vaccine shot has been approved in the U.S. for immunocompromised people, and vaccine boosters are expected to be available to the general public sometime after Sept. 20, Walgreens and CVS have lost no time in offering the additional shot to those who qualify. Like their previous policies for vaccine shots and […]
Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity — or muscle stiffness and spasms — in adults with multiple sclerosis (MS), remains unavailable to many patients there, according to a report by the MS Society UK. Sativex is the only licensed form of medical cannabis for MS in the U.K., […]
PoNS, a non-invasive devise to accompany physical therapy in multiple sclerosis (MS) patients with difficulty walking, will be available on the U.S. market early next year, its developer, Helius Medical Technologies, announced in a quarterly financial update. Short for Portable Neuromodulation Stimulator, the PoNS system was cleared by the U.S. Food and Drug Administration (FDA) in […]
